Javascript must be enabled to continue!
Comparison between thulium laser resection of prostate and transurethral plasmakinetic resection of prostate or transurethral resection of prostate
View through CrossRef
AbstractBenign prostatic hyperplasia (BPH) is one of the most common diseases in middle-aged and elderly men. In the present study, we aimed to compare the efficacy and safety of thulium laser resection of the prostate (TMLRP) with either transurethral plasmakinetic resection of the prostate (TUPKP) or transurethral resection of the prostate (TURP). A literature search was performed, eventually, 14 studies involving 1587 patients were included. Forest plots were produced by using Revman 5.2.0 software. Our meta-analysis showed that operation time, decrease in hemoglobin level, length of hospital stay, catheterization time and development of urethral stricture significantly differed, whereas the transitory urge incontinence rate, urinary tract infection rate and recatheterization rate did not significantly differ between TMLRP and either TURP or TUPKP. The blood transfusion rate was significantly different between TMLRP and TURP, but not between TMLRP and TUPKP. In addition, the retrograde ejaculation rate between TMLRP and TURP did not significantly differ. At 1, 3, 6 and 12 months of postoperative follow-up, the maximum flow rate, post-void residual, quality of life and International Prostate Symptom Score did not significantly differ among the procedures. Thus, the findings of this study indicate that TMLRP may be a safe and feasible alternative.
Springer Science and Business Media LLC
Title: Comparison between thulium laser resection of prostate and transurethral plasmakinetic resection of prostate or transurethral resection of prostate
Description:
AbstractBenign prostatic hyperplasia (BPH) is one of the most common diseases in middle-aged and elderly men.
In the present study, we aimed to compare the efficacy and safety of thulium laser resection of the prostate (TMLRP) with either transurethral plasmakinetic resection of the prostate (TUPKP) or transurethral resection of the prostate (TURP).
A literature search was performed, eventually, 14 studies involving 1587 patients were included.
Forest plots were produced by using Revman 5.
2.
0 software.
Our meta-analysis showed that operation time, decrease in hemoglobin level, length of hospital stay, catheterization time and development of urethral stricture significantly differed, whereas the transitory urge incontinence rate, urinary tract infection rate and recatheterization rate did not significantly differ between TMLRP and either TURP or TUPKP.
The blood transfusion rate was significantly different between TMLRP and TURP, but not between TMLRP and TUPKP.
In addition, the retrograde ejaculation rate between TMLRP and TURP did not significantly differ.
At 1, 3, 6 and 12 months of postoperative follow-up, the maximum flow rate, post-void residual, quality of life and International Prostate Symptom Score did not significantly differ among the procedures.
Thus, the findings of this study indicate that TMLRP may be a safe and feasible alternative.
Related Results
Thulium: yttrium-aluminiumgarnet laser transurethral vapoenucleation – a new standard in the surgical treatment of large benign prostatic hyperplasia
Thulium: yttrium-aluminiumgarnet laser transurethral vapoenucleation – a new standard in the surgical treatment of large benign prostatic hyperplasia
Introduction. According to the current recommendations of the European Association of Urology and the International Society of Urology, open simple prostatectomy is the reference s...
Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer
Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer
Objective: To compare the efficiency and safety profile of conventional monopolar, bipolar plasmakinetic and holmium laser techniques for transurethral resection of bladder tumour....
Brοadband emitting materials dοped with thulium and hοlmium iοns fοr sοlid-state lasers at 2 μm and beyοnd
Brοadband emitting materials dοped with thulium and hοlmium iοns fοr sοlid-state lasers at 2 μm and beyοnd
Matériaux à large bande d'émission dopés avec des ions thulium et holmium pour des lasers à l'état solide à 2 μm et au-delà.
De nouveaux matériaux inorganiques acti...
Comparison of the clinical efficacy of holmium and thulium ureterolithotripsy
Comparison of the clinical efficacy of holmium and thulium ureterolithotripsy
Introduction. Urolithiasis is one of the most common pathologies in modern urology. This disease is registered in 10% of the population and is manifested by an annual increase. Des...
LEO-to-GNSS Laser Interferometer for Space Geodesy with Laser DORIS and Laser SAR
LEO-to-GNSS Laser Interferometer for Space Geodesy with Laser DORIS and Laser SAR
In order to increase the accuracy of precise orbit determination for a single satellite or satellites in LEO formation, we propose using a LEO-to-GNSS laser interferometer, what we...
Laser Spectrometric Techniques in Analytical Atomic Spectrometry
Laser Spectrometric Techniques in Analytical Atomic Spectrometry
Abstract
Laser light has a number of spectacular properties that make it useful for analytical spectrometry. One is that it has a high directionality (i.e. i...
Treatment of burn scars in Fitzpatrick phototype III patients with a combination of pulsed dye laser and non-ablative fractional resurfacing 1550 nm erbium:glass/1927 nm thulium laser devices
Treatment of burn scars in Fitzpatrick phototype III patients with a combination of pulsed dye laser and non-ablative fractional resurfacing 1550 nm erbium:glass/1927 nm thulium laser devices
Introduction: Burn scars cause cosmetic disfigurement and psychosocial distress. We present two Fitzpatrick phototype (FP) III patients with burn scars successfully treated with co...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...

